PRODUCT DESCRIPTION:

Testomix is an intramuscularly administered androgenic steroid designed for testosterone replacement therapy providing a balanced release of testosterone due to its multiple esters. It combines four esters of natural hormone testosterone and addresses hypogonadal disorders in males, particularly those related to testosterone deficiency.

COMPOSITION:

Each milliliter contains a blend of testosterone esters: Testosterone Propionate 30 mg, Phenylpropionate 60 mg, Isocaproate 60 mg, and Decanoate 100 mg.

DRUG CLASS:

Classified under anabolic/androgenic steroids.

DOSAGE:

Dosage should be adjusted based on the individual patient's response. Typically, a single 1 ml injection every four weeks is sufficient.

INDICATIONS:

Primarily indicated for testosterone replacement therapy in males with hypogonadal disorders, including conditions such as castration, eunuchoidism, hypopituitarism, and osteoporosis due to male androgen deficiency.

CONTRAINDICATIONS:

Contradicted in males with known or suspected mammary or prostatic carcinoma. Not intended for use in female patients.

SIDE EFFECTS AND PRECAUTIONS:

In case of androgen-associated adverse reactions, treatment interruption is recommended. Resume at a lower dosage after symptoms disappear. Caution is advised in patients with cardiac failure, renal dysfunction, hypertension, epilepsy, or migraine. Prepubescent boys should use androgens cautiously to avoid premature epiphyseal closure or precocious sexual development. A decrease in protein-bound iodine may occur, but it is clinically insignificant. Middle-aged and elderly males with severe circulatory diseases, such as angina pectoris, should undergo androgen treatment with careful supervision.

STORAGE:

Keep in a cool, dry place away from light and out of reach of children.